Profit Or Loss [Abstract]

Egetis Therapeutics - Filing #5995613

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Cost of sales
116,000,000 SEK
110,000,000 SEK
Gross profit
345,000,000 SEK
466,000,000 SEK
Other income
52,000,000 SEK
89,000,000 SEK
Administrative expenses
1,056,000,000 SEK
862,000,000 SEK
Profit (loss) from operating activities
3,294,000,000 SEK
3,248,000,000 SEK
Finance income
165,000,000 SEK
49,000,000 SEK
Finance costs
259,000,000 SEK
42,000,000 SEK
Profit (loss) before tax
3,432,000,000 SEK
3,268,000,000 SEK
Tax expense (income)
3,000,000 SEK
1,000,000 SEK
Profit (loss)
3,436,000,000 SEK
3,269,000,000 SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
11.0
13.0
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
11.0
13.0

Talk to a Data Expert

Have a question? We'll get back to you promptly.